NCT03091634View on ClinicalTrials.gov

The Efficacy and Safety of the Xue-Fu-Zhu-Yu Capsule in Treatment of Qi Stagnation and Blood Stasis Syndrome.

PHASE2CompletedINTERVENTIONAL
Enrollment

120

Participants

Timeline

Start Date

May 6, 2017

Primary Completion Date

October 31, 2018

Study Completion Date

December 31, 2018

Conditions
Qi Stagnation and Blood Stasis Syndrome
Interventions
DRUG

xue-fu-zhu-yu capsule

participants are given to 6 xue-fu-zhu-yu capsule per time, twice a day. The duration is 7 weeks

DRUG

xue-fu-zhu-yu capsule simulated agent

participants are given to 6 xue-fu-zhu-yu capsule simulated agent per time, twice a day. The duration is 7 weeks

Trial Locations (3)

100053

Guang'anmen Hospital, China Academy of Chinese Medical Sciences, Beijing

Unknown

Huguosi TCM Hospital Affiliated to Beijing University of CM, Beijing

Wangjing Hospital, China Academy of Chinese Medical Sciences, Beijing

All Listed Sponsors
collaborator

China Food and Drug Administration

OTHER_GOV

collaborator

Chinese Academy of Medical Sciences

OTHER

lead

Guang'anmen Hospital of China Academy of Chinese Medical Sciences

OTHER

NCT03091634 - The Efficacy and Safety of the Xue-Fu-Zhu-Yu Capsule in Treatment of Qi Stagnation and Blood Stasis Syndrome. | Biotech Hunter | Biotech Hunter